Bentham Science news roundup
Journal Updates and Offers
Bentham Science Publishers is pleased to announce that MicroRNA has now been awarded an Impact Factor ranking by Clarivate Analytics. The journal - currently edited by Dr. Alberto Izzoti (University of Genoa) – has been providing readers with cutting-edge research on the molecular biology and therapeutic applications of MicroRNAs. Bentham Science Wishes to congratulate all journal contributors, including editors, authors and staff involved with the journal since its inception.
Impact Factor Update: With MicroRNA’s addition to the Impact Factor list, 67 journals now have this distinction. Current Neuropharmacology continues to lead the list with a rating of 5.3 for 2024, followed by Recent Patents on Anti-Cancer Drug Discovery (4.1) and Current Medicinal Chemistry (3.5). Bentham Science is committed to publishing impactful research in the years to come.
Bentham Science Publishers thanks everyone who has contributed to our mission of promoting science and upholding our values of scientific integrity.
Updated list of Bentham Science Journals with Impact Factors:
$0 APC Publishing Opportunities for Researchers Across Select Global Institutions
Bentham Science is pleased to announce multiple Open Access publishing opportunities for researchers affiliated with select universities and research institutions across Asia, Europe, North America, and Latin America. Under these agreements and pilot programs, eligible authors can publish their research as Gold Open Access with a full Article Processing Charge (APC) waiver (i.e., $0 APC)—subject to standard peer review and editorial acceptance.
These initiatives aim to broaden access to high-quality scientific publishing and support researchers by removing financial barriers to Open Access publication.
Current Publishing Opportunities by Country
Japan
Researchers from over 100 participating institutions are eligible under the national Open Access Publishing Trial. Learn more.
Trial ends: 31st December 2025
Chile
Eligible for all institutions under the CINCEL Consortium.
Trial ends: 31st December 2025
Armenia
All national research institutions and universities are included.
Trial ends: 31st December 2025
Moldova
Open to researchers from all Moldovan institutions.
Trial ends: 31st December 2025
Cyprus
Researchers from all academic and research institutions in Cyprus are eligible.
Trial ends: 31st December 2025
China
Researchers affiliated with the Chinese Academy of Sciences may publish at $0 APC.
Trial ends: 31st August 2025
Read & Publish Agreements
In addition to the Open Access trials, Bentham Science has signed Read and Publish agreements with several leading institutions in the United States and Italy. Authors affiliated with the following universities can publish Gold Open Access articles in Bentham Science journals without any APC:
United States
• Northeastern University
• University of Washington in St. Louis
Italy
• University of Bologna
• University of Siena
• University of Parma
• University of Trieste
• University of Genoa
Learn more about the benefits for Member Institutions having Read and Publish arrangements with Bentham Science here.
Bentham Science Editor-in-Chief Dr. Kenneth Blum Appointed Honorary President of Global Institute for Preventive Medicine and Longevity (GIPML)
Bentham Science Publishers proudly congratulates Dr. Kenneth Blum, Editor-in-Chief of the journal Current Psychopharmacology, on his appointment as Honorary President of the newly formed Global Institute for Preventive Medicine and Longevity (GIPML).
The announcement comes from Ariel University (Israel), which is establishing GIPML as a forward-thinking international research institute focused on personalized and preventive medicine, stress and community resilience, and healthy living and longevity promotion. The institute will connect leading scientists from the United States, Israel, and Europe to advance multidisciplinary solutions in healthcare and aging.
This appointment is a well-deserved recognition of Dr. Blum’s exceptional contributions to neuroscience, genetics, and behavioral medicine, which have had a transformative impact on global health research. His editorial leadership at Current Psychopharmacology, published by Bentham Science, reflects his deep commitment to advancing rigorous, innovative science.
“We are honored to see one of our distinguished Editors receive this prestigious international role,” said a spokesperson for Bentham Science. “Dr. Blum’s visionary work and leadership continue to shape the future of psychopharmacology and translational medicine.”
As Honorary President of GIPML, Dr. Blum will help guide the institute’s global outreach and scientific mission—advancing the frontiers of medicine and improving quality of life worldwide.
New Editors-in-Chief
We welcome new journal Editors.
Spiros Paramithiotis, University of Ioannina - Editor-in-Chief, Current Probiotics
Davide Barreca, University of Messina - Editor-in-Chief, Mini-Reviews in Medicinal Chemistry
Fanglin Guan, Xi’an Jiaotong University Health Science Center - Editor-in-Chief, Current Gene Therapy
Yuwei Wang, Shaanxi University of Chinese Medicine - Editor-in-Chief, Current Drug Metabolism
Yalong Dang, Sanmenxia Eye Hospital (Eye Institute), The Open Ophthalmology Journal
Maria M. Marrapodi, University of Campania Luigi Vanvitelli - Editor-in-Chief, Open Medicine Journal
Francesca Duraturo, University of Naples “Federico II”- Editor-in-Chief, The Open Biomarkers Journal
Maurizio Marvisi, Istituto Figlie di S. Camillo - Editor-in-Chief, The Open Respiratory Medicine Journal
Upcoming Thematic Issues
Here’s a list of upcoming journal issues focused on special topics with active calls for papers.
Approaches to the Treatment of Chronic Inflammation
Computational modeling of potential targets and lead screening against Monkeypox viruses
Innovative Drug Research Propelling a New Era of Precision Oncology
Search for journal thematic issues here. You can also filter issues by status, journal, SDGs and subjects.
New Books from Bentham Science
Explore some new books from our shelf:
✔ Advanced Machine Learning for Complex Medical Data Analysis
✔ Viral Outbreaks: 2019-2023 Overview
✔ Cryptocurrency Market Forecasting With Catboost Models
✔ Anthraquinones: Bioactive Multifaceted Therapeutic Agents
✔ Bioactive Compounds Targeting Neurodegenerative Diseases
✔ Wild Vegetables: Morphology, Phytochemistry and Utility - Part 1
✔ Advancements in Artificial Intelligence and Machine Learning
✔ Promising Cancer Therapeutic Drug Targets: Recent Advancements
✔ Nanotechnology for Wastewater Treatment
✔ Beyond Blockchain: Reviewing the Impact and Evolution of Decentralized Networks (Part 1)
✔ Data Alchemy in Insurance: Revolutionizing the Insurance Industry through Big Data Analytics
✔ Nanomaterials in Biological Milieu: Biomedical Applications and Environmental Sustainability
✔ Spinal Surgery Biomechanics: Principles for Residents and Students
✔ Antibiotics and Reproductive Health
✔ Advanced Computing Solutions for Healthcare
✔ Nanomaterials, Metamaterials, and Smart Materials: Synthesis and Characterization
✔ Mucosal Vaccine Delivery Systems: The Future of Immunization (Part 1)
✔ Zebrafish Models for Experimental Pharmacology: A Handbook
You can get 30% off on all books and articles through our online store throughout 2025 by using the code BSP25.